Evidence map›Paper›PMID 35396866›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2022

A Positron Emission Tomography Ligand for Mutant Huntingtin Sheds Light on Disease.

Andrew P Lieberman, Roger L Albin

Abstract readComment
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Andrew P LiebermanDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.ORCID 0000-0001-9032-580X
Roger L AlbinDepartment of Neurology, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Funding

Research Education ComponentP30AG072931 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DOUGLAS C NOLL · 2021 to 2026
$26.5M
Udall Catalyst Research Project: Retrosplenial Cholinergic and Attentional-Motor Integration DysfunctionP50NS123067 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AHMED, OMAR JAMIL · 2021 to 2025
$11.6M
Michigan Alzheimer's Disease Core CenterP30AG053760 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALBIN, ROGER L · 2016 to 2020
$10.1M
Mechanisms of motor neuron toxicity in Kennedy DiseaseR01NS055746 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIEBERMAN, ANDREW P, OSAWA, YOICHI · 2007 to 2021
$6.0M
Therapeutic Targets for Niemann-Pick Type C NeurodegenerationR01NS122746 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIEBERMAN, ANDREW P · 2021 to 2025
$3.0M
Mechanisms of neuromuscular degeneration in SBMAR01NS119873 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIEBERMAN, ANDREW P · 2021 to 2025
$2.7M
Determining the role of AR transcriptional function in SBMAR01NS106302 · NINDS · THOMAS JEFFERSON UNIVERSITY · PI MERRY, DIANE E · 2019 to 2023
$2.2M
Training Program in Translational ResearchT32GM141840 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDREW P LIEBERMAN, Zaneta Nikolovska-Coleska · 2021 to 2026
$2.0M
Optimization of synthetic HDL nanoparticles for treatment Niemann-Pick Type CR21NS111191 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHWENDEMAN, ANNA · 2019 to 2019
$429k
Exploring the Roles of Manganese in NeuronsR21NS112974 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SEO, YOUNG AH · 2020 to 2020
$429k
Vigor and the LDR in Parkinson diseaseR21NS114749 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALBIN, ROGER L · 2020 to 2020
$390k
NIA NIH HHS P30 AG053760NIA NIH HHS P30 AG072931NIGMS NIH HHS T32 GM141840NINDS NIH HHS P50 NS123067NINDS NIH HHS R01 NS055746NINDS NIH HHS R01 NS106302NINDS NIH HHS R01 NS119873NINDS NIH HHS R01 NS122746NINDS NIH HHS R21 NS111191NINDS NIH HHS R21 NS112974NINDS NIH HHS R21 NS114749
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Huntington DiseasePositron-Emission TomographyHumansHuntingtin ProteinLigandsMutationHuntingtin ProteinLigands

Identifiers

PMID35396866
PMCPMC9182207

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.